The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Considerable evidence suggests that aspirin has a chemopreventive effect on colorectal cancer (CRC). However, optimal dose and treatment duration have not been defined, and data on the effects of low-dose aspirin are contradictory.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Aliment. Pharmacol. Ther.

Title: Alimentary pharmacology & therapeutics

ISSN (Electronic): 1365-2036

ISSN (Print): 0269-2813

Publication date (Electronic): Aug 2013

Volume: 38

Issue: 4

Affiliations

[1 ] Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Article

DOI: 10.1111/apt.12388

PubMed ID: 23799975

SO-VID: 5ac1de79-691f-4d85-8229-cc5c6fdfd0f7

History

Data availability:

Comments

Comment on this article

scite_

Cited by 10

See all cited by